Important information when registering for ESGE Days 2022
Last updated: November 23, 2021
ESGE is looking forward to hosting ESGE Days 2022 as a hybrid event. For those who can travel and participate in person, we look forward to meeting you in Prague. To those who are unable to be present physically, we look forward to welcoming you virtually as an integral component of this event.
The safety of all our registrants and conference attendees is of utmost importance. The COVID-19 policy specified below is based on current pandemic conditions and will be adjusted according to actual conditions at the time of the event.
Before registering, please ensure you have read this page fully. By registering for the hybrid package, you agree to fully comply with all COVID-19 regulations required onsite as defined by the event organiser.
Currently, delegates will be required to wear masks at all times throughout the congress venue.
Please note that delegates providing only a valid negative PCR, antigen or antibody test certificate will not be granted access to the congress.
The Prague Congress Center and local service providers have been asked to ensure that any unvaccinated staff will be required to test on a daily basis and that they should not be permitted access to public areas.
ESGE is constantly monitoring the COVID-19 status and will follow guidance and advisories from the Ministry of Health in the Czech Republic as well as the standards set forth by the Prague Congress Center. Please refer to this website for updates regarding the ESGE Days 2022 COVID-19 policy.
Registration to ESGE Days 2022 opens on December 1, 2021.
*Please ensure that the vaccine you received has been approved by the European Medicines Agency (EMA). Information on approved vaccines within the European Union can be found on the homepage of the European Commission or EMA directly (https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/treatments-vaccines/vaccines-covid-19/covid-19-vaccines-authorised#safety-updates-for-authorised-covid-19-vaccines-section).